Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Futura Medical (FUM) Share Price

Intraday
Historical

Price	13.40p on 28-02-2025 at 17:30:00
Change	-0.16p -1.18%
Buy	13.38p
Sell	13.00p
Buy / Sell FUM Shares

Last Trade:	Sell 18,787.00 at 13.0988p
Day's Volume:	144,416
Last Close:	13.40p
Open:	13.56p
ISIN:	GB0033278473

Day's Range	13.00p - 13.56p
52wk Range:	12.20p - 45.40p
Market Capitalisation:	£41m
VWAP:	13.15517p
Shares in Issue:	304m

Sector: Medicine and Biotech

Listed In: FTSE AIM All-Share,

Buy/Sell	Volume	Trade Prc	Trade Type	Trade Time
Futura Medical (FUM) Latest Trades
Sell*	18,787	13.0988p	Ordinary	15:11:30 - 28-Feb-25
Sell*	2,195	13.0988p	Ordinary	14:12:50 - 28-Feb-25
Sell*	972	13.00p	Automatic Execution	14:07:12 - 28-Feb-25
Sell*	551	13.00p	Automatic Execution	14:07:12 - 28-Feb-25
Sell*	250	13.00p	SI Trade	14:07:09 - 28-Feb-25
Buy*	57	13.38p	SI Trade	14:07:09 - 28-Feb-25
Buy*	499	13.38p	SI Trade	14:07:09 - 28-Feb-25
Buy*	200	13.38p	SI Trade	14:07:09 - 28-Feb-25
Sell*	14,449	13.00p	Automatic Execution	14:07:09 - 28-Feb-25
Sell*	15,000	13.00p	Automatic Execution	14:07:09 - 28-Feb-25

See more Futura Medical trades

Futura Medical (FUM) Share Price History
Time period: to
Date	Open	High	Low	Close	Volume
28th Feb 2025 (Fri)	13.56	13.56	13.00	13.40	144,416
27th Feb 2025 (Thu)	13.20	14.18	13.04	13.56	1,094,255
26th Feb 2025 (Wed)	12.52	13.18	12.52	12.90	177,603
25th Feb 2025 (Tue)	13.24	13.32	12.50	12.95	580,591
24th Feb 2025 (Mon)	13.48	13.48	13.16	13.24	451,340
21st Feb 2025 (Fri)	13.80	14.18	12.20	13.66	1,137,122
20th Feb 2025 (Thu)	14.50	14.68	14.20	14.29	1,023,653
19th Feb 2025 (Wed)	14.16	14.88	14.14	14.58	1,018,004
18th Feb 2025 (Tue)	14.00	14.80	14.00	14.80	1,300,590
17th Feb 2025 (Mon)	13.90	14.00	13.80	14.00	434,296
14th Feb 2025 (Fri)	14.00	14.78	14.00	14.39	477,494
13th Feb 2025 (Thu)	14.00	14.84	14.00	14.00	506,192
12th Feb 2025 (Wed)	14.98	15.00	14.00	14.27	902,096
11th Feb 2025 (Tue)	13.80	14.50	13.64	14.10	608,799
10th Feb 2025 (Mon)	13.60	14.80	13.40	13.40	1,208,544
7th Feb 2025 (Fri)	15.10	15.10	12.80	13.40	4,458,266
6th Feb 2025 (Thu)	17.20	17.20	15.10	15.10	628,935
5th Feb 2025 (Wed)	16.50	17.98	15.90	15.90	538,467
4th Feb 2025 (Tue)	16.46	16.50	16.30	16.30	481,048
3rd Feb 2025 (Mon)	16.96	17.98	16.20	16.46	1,281,444

See more Futura Medical price history

Date	Source	Headline
Futura Medical (FUM) Regulatory News
30th Jan 2025 7:00 am	RNS	FY24 Trading Update and FY25 Outlook
15th Jan 2025 7:00 am	RNS	Positive results from WSD4000 Home User study
13th Jan 2025 7:00 am	RNS	Remuneration of Non-Executive Directors and TVR's
20th Dec 2024 7:58 am	RNS	Holding(s) in Company
2nd Dec 2024 7:00 am	RNS	Block Listing Six Monthly Return
15th Nov 2024 7:00 am	RNS	TR-1: Notification of major holdings
4th Nov 2024 7:00 am	RNS	Encouraging New Product Development Pipeline
31st Oct 2024 7:00 am	RNS	Total Voting Rights
7th Oct 2024 7:00 am	RNS	Further milestone payment triggered post US launch
1st Oct 2024 7:00 am	RNS	Total Voting Rights

See more Futura Medical regulatory news

Futura Medical (FUM) Share News

After bumper 2024, Futura warns of lower 2025 sales on slow US uptake

31st Jan 2025 11:39

(Alliance News) - Futura Medical PLC on Friday said it expects 2024 revenue and post-tax profit ahead of guidance, but warned of 2025 sales below market expectations, due to slow uptake in the US of its erectile dysfunction treatment. Read More

AIM WINNERS & LOSERS: Kromek wins deal; Futura Medical warns on profit

30th Jan 2025 11:03

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Thursday. Read More

IN BRIEF: Futura gets good results for female sexual dysfunction aid

16th Jan 2025 09:37

Futura Medical PLC - Guildford, Surrey-based sexual health products - Shares rise 4.5% on Wednesday as Futura reports positive results from a 'sensory' study of its WSD4000 treatment for sexual dysfunction in women. Futura explains that a sensory study assesses how healthy volunteers perceive product characteristics through their senses. The study involved 67 women with some degree of sexual dysfunction, and WSD4000 produced a positive change in a majority of them after four weeks. "Following the success of the study, alongside market research on the size of the opportunity following commercialisation, the board is recommending to proceed with an early feasibility study during H1 2025," Futura says. Read More

Futura Medical progresses study of female sexual dysfunction treatment

4th Nov 2024 10:57

(Alliance News) - Futura Medical PLC on Monday said it has progressed the development of its new product pipeline, including treatments for sexual dysfunction in both men and women. Read More

IN BRIEF: Futura Medical US pre-orders trigger milestone payment

7th Oct 2024 11:06

Futura Medical PLC - Surrey-based sexual health products company - Announces that the next milestone payment of USD5.0 million, due under its agreement with Haleon PLC, has been triggered by Haleon's distribution of online pre-orders and the availability of Eroxon in US retailers. Eroxon is a fast-acting gel used to treat erectile dysfunction, which has been available without a prescription in UK pharmacies since March last year. Futura Medical struck a licensing deal with Haleon for the gel in July 2023, which has led to its availability in the US from October this year. Futura Medical expects to receive the payment from Haleon shortly. Read More

See more Futura Medical news

FTSE 100 Latest

Value8,809.74

Change53.53

Futura Medical (FUM) Share Price

Login to your account